Payne Christopher D reported option exercise involving 545 shares of Hims Hers Health, Inc. on Aug 14, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Director
DIR
Filed Aug 18, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
—Shares × reported price
Shares traded
545Class A Common Stock
Price per share
Price unknownReported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
34,863Direct
Trade date
Aug 14, 2026Option exercise
Filed
Aug 18, 2026, 5:03 PM ET4-day reporting delay
Accession
0001773751-26-000205Code M · Transaction 2988
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Aug 14, 2026Option exercise545$0.00$0Trade 2989
2 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

HIMS price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
HIMS · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +37%1w ago +13%1d ago +13%
Returns since7d +16%30d +1.8%90d −32%180d1y

Footnotes in full

F1: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date.